Piscitelli Dominic's Form 4 filing
Oric Pharmaceuticals, Inc. (ORIC) · filed Sep 25, 2026
- Accession no.
- 0001695028-26-000008
- Filed
- Sep 25, 2026, 7:59 PM ET
- Trade date
- Sep 24, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $8.10K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Piscitelli DominicCIK 0001695028 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | MOption exerciseAcquired | +600 | $4.36 | +$2,616 | 70,428 | Direct | |
| Sep 24, 2026 | Common Stock | SSaleDisposed | −100 | $13.50 | −$1,350 | 70,328 | Direct | |
| Sep 24, 2026 | Common Stock | SSaleDisposed | −500 | $13.51 | −$6,752.5 | 69,828 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | MOption exerciseDisposed | −600 | $0.00 | $0 | 91,900 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.